ClinicalTrials HQ

Tanta Unuversity

Tanta Unuversity

Tanta, Egypt

10 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Metformin in Safety and Efficacy in Gouty PatientsCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorderRecruitingPhase 22026-09-30NCT06924658
Allopurinol in Depressiondepressive disorderRecruitingPhase 2 / Phase 32026-08-18NCT07574060
Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography PancreatitisDigestive System Diseases, biliary tract disorder, gallbladder disorderRecruitingPhase 32026-08-18NCT06860984
Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease PatientsDigestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver diseaseRecruitingPhase 22026-05-04NCT06863376
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patientsdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-05-04NCT06860958
Investigating the Pathophysiological Nature of Homosexualitypsychiatric disorderRecruitingNot stated2026-03-16NCT05897177
Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography PancreatitisDigestive System Diseases, pancreas disorderRecruitingPhase 32026-03-13NCT06861010
Erdosteine in the Treatment of Nonalcoholic Fatty Liver DiseaseDigestive System Diseases, fatty liver disease, liver disorderRecruitingPhase 1 / Phase 22025-12-10NCT07242222
Vinpocetine in Patients With Parkinsonian DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingPhase 2 / Phase 32025-12-10NCT07229664
Celecoxib in Parkinson Disease as Adjuvant TherapyParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingPhase 1 / Phase 22025-12-05NCT07246278